ProFound AI is a high-performance, deep-learning workflow solution trained to detect malignant soft-tissue densities and calcifications. The event, which will be moderated by Michael Klein, Chairman and CEO of iCAD, Inc., Stacey Stevens, President of iCAD, Inc., and Jeffrey Sirek, Chief Commercial Officer of iCAD, Inc., will feature a roundtable discussion on iCAD’s Breast Health Solutions, including ProFound ® AI, the world’s first artificial intelligence (AI) software application trained using deep-learning technology on digital breast tomosynthesis (DBT) images to be FDA cleared. Smith, MD, Dermatologist, Chief Executive Officer, Georgia Skin and Cancer Clinic Matt Dewey, Chief Information Officer, Wake Radiology.
Meghan Musser, DO, Radiologist, Kettering Health.Sally Grady, Director, Kettering Breast Evaluation Centers, Kettering Health.Angela Fried, MD, Director of Breast Imaging, SimonMed Imaging.The following leading experts will be featured during the webinar: “With a robust portfolio of advanced technologies for the detection and treatment of cancers that continues to improve each year, iCAD’s unique solutions enhance clinical efficiency across the entire continuum of breast health care, from screening and diagnosis through treatment, offering economic benefits to customers and ultimately improving outcomes for patients.” “Our virtual investor webinar was incredibly well-received last year, and we look forward to making this an annual event where we can connect the investment community with leading experts who can provide unique viewpoints on the performance superiority, productivity yields, and broad healthcare economic value proposition iCAD's technology offers,” according to Stacey Stevens, President of iCAD, Inc. To register for the event, please visit this link. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will host its 2 nd annual virtual investor webinar, featuring leading clinical and administrative experts who will share unique perspectives on iCAD’s innovative cancer detection and treatment technologies, on Thursday, November 18, 2021, from 3:00 to 4:30 PM Eastern Time.
Webinar taking place on Thursday, November 18 from 3:00 to 4:30 PM ET Leading clinical and administrative experts to discuss how leveraging iCAD’s Breast Health Solutions and the Xoft System can enhance clinical efficiency and improve outcomes for patients
0 kommentar(er)
